Hello Jburd,
According to Bernstein Research report from May 2005, sales of
diabetes-related drugs exceeded $12 billion.
Excerpts:
"Sales of diabetes-related drugs exceeded $12 billion in 2004,
according to a May 25 report by Bernstein Research. Diabetes-related
drug sales are expected to jump 12 percent annually through 2011
worldwide, compared to industry-wide sales growth of 6 percent, said
the Bernstein report.
Producing insulin is a big money-maker for the industry. Eli Lilly &
Co. (down $0.38 to $56.99, Research) and Novo Nordisk (up $0.21 to
$50.63, Research) each made more than $2 billion last year from
insulin and Sanofi-Aventis (down $0.50 to $43.80, Research) made $1
billion.
TZDs, pills that help the body make its own insulin, are also
profitable. GlaxoSmithKline (up $0.18 to $50.18, Research) made more
than $2 billion from TZD sales in 2004 and Takeda Pharmaceutical made
more than $1 billion.?
(?)
?The Bernstein report said 90 percent of the growth in diabetes drugs
will go to large cap companies, including Pfizer, Merck & Co.,
Novartis, Lilly, GlaxoSmithKline, Takeda, Sanofi, Novo Nordisk,
Bristol-Myers Squibb and Astra-Zeneca.?
Leading Treatments
------------------------------
Drug 2004 sales
------------------------------
Humulin $1B
Humalog $1.1B
Avandia/ Avandamet $2.1B
Human insulin $2.2B
Lantus $1B
Amaryl $815M
Actos $1.3B
Basen $1B
------------------------------
Source:
Diabetes: New treatments, big bucks
Treating diabetes is projected to be one of the most profitable
sectors in the drug industry.
CNN/Money : June 9, 2005
http://money.cnn.com/2005/06/08/news/fortune500/diabetes/
=============================================
?Diabetes became one of the top 10 therapeutic markets in 2004, when
sales of diabetes-related drugs exceeded $12 billion, the report said.
From 2004 to 2011, the diabetes market is expected to account for 8
percent of total drug industry growth and will increase from 3 percent
to 5 percent of total drug sales, the report said.
The report was authored by Bernstein analysts Richard Evans, Gbola
Amusa, Devesh Gandhi, Daniel Kranson and Courtney Le Vine?
CNN Money: May 2005
http://64.233.161.104/search?q=cache:Ri6XKf6lrMgJ:money.cnn.com/2005/05/25/news/fortune500/bernstein/+%22sales+of+diabetes+drugs%22&hl=en
=============================================
Growth - $30 billion by 2009
?Industry observers said that sales of diabetes drugs should total $30
billion by 2009 as new treatments hit the market. The epidemic of
childhood obesity is expected to boost sales in the future of diabetes
drugs.?
KPMG Pharmaceutical Insider Quarterly Digest, Third Quarter 2005.
http://www.kpmginsiders.com/display_analysis.asp?cs_id=147135
=============================================
Search criteria:
"diabetes drugs" sales billion
I hope the information provided is helpful!
Best regards,
Bobbie7 |
